文献速递慢性肾脏病血液净化与透析

晚期慢性肾脏病中有机溶质肾小管分泌受损

Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2021-08-18

该研究纳入16例eGFR为7±2 ml/min/1.73 m²的晚期CKD患者和16名对照,用代谢组学分析同时采集的血浆和尿液,发现对照组中39种分泌型溶质的分数清除率>3.0,而CKD患者分数清除率平均降至对照的65%±27%,其中18种溶质显著降低。结论认为晚期CKD中多种溶质的分泌清除率下降程度超过GFR下降,可能促进尿毒症症状。

要点

  • 晚期CKD患者多种分泌型溶质的分数清除率显著低于对照。
  • 39种分泌型溶质中18种分数清除率显著降低,仅1种显著升高。
  • 苯乙酰谷氨酰胺、对甲酚硫酸盐和吲哚硫酸盐清除受损,马尿酸盐无显著差异。

核心结论

  • 晚期CKD中多种溶质的分泌清除率下降程度超过GFR下降。
  • 这些溶质分泌受损可能促进患者接近透析时的尿毒症症状。

研究设计与样本

  • 研究纳入16例eGFR为7±2 ml/min/1.73 m²的CKD患者和16名对照参与者。
  • 采用代谢组学分析同时采集的血浆和尿液样本。
  • 分数清除率按各溶质尿/血浆浓度比相对于肌酐和尿素(CKD患者)或肌酐(对照)的比值计算。

主要发现

  • 对照组中鉴定出39种分数清除率>3.0的分泌型溶质。
  • CKD患者分数清除率平均降至对照的65%±27%。
  • 39种溶质中18种分数清除率显著降低,仅1种显著升高。
  • 苯乙酰谷氨酰胺分数清除率:对照4.2±0.6 vs CKD 2.3±0.6,P<0.001。
  • 对甲酚硫酸盐分数清除率:对照8.6±2.6 vs CKD 4.1±1.5,P<0.001;吲哚硫酸盐:23.0±7.3 vs 7.5±2.8,P<0.001;马尿酸盐:10.2±3.8 vs 8.4±2.6,P=0.13。

关键数值与推荐

  • 分泌型溶质定义为对照组中分数清除率>3.0的溶质。
  • CKD患者分数清除率平均为对照的65%±27%。

临床怎么用

  • 评估晚期CKD毒素清除时需关注肾小管分泌功能受损,而不仅依赖GFR。
  • 苯乙酰谷氨酰胺、对甲酚硫酸盐和吲哚硫酸盐的分泌清除受损可能参与尿毒症症状。

局限性

  • 样本量较小(16例CKD患者和16名对照)。
  • 横断面设计,未评估分泌清除率变化与临床结局的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The clearance of solutes removed by tubular secretion may be altered out of proportion to the GFR in CKD. Recent studies have described considerable variability in the secretory clearance of waste solutes relative to the GFR in patients with CKD. METHODS: To test the hypothesis that secretory clearance relative to GFR is reduced in patients approaching dialysis, we used metabolomic analysis to identify solutes in simultaneous urine and plasma samples from 16 patients with CKD and an eGFR of 7±2 ml/min per 1.73 m2 and 16 control participants. Fractional clearances were calculated as the ratios of urine to plasma levels of each solute relative to those of creatinine and urea in patients with CKD and to those of creatinine in controls. RESULTS: Metabolomic analysis identified 39 secreted solutes with fractional clearance >3.0 in control participants. Fractional clearance values in patients with CKD were reduced on average to 65%±27% of those in controls. These values were significantly lower for 18 of 39 individual solutes and significantly higher for only one. Assays of the secreted anions phenylacetyl glutamine, p-cresol sulfate, indoxyl sulfate, and hippurate confirmed variable impairment of secretory clearances in advanced CKD. Fractional clearances were markedly reduced for phenylacetylglutamine (4.2±0.6 for controls versus 2.3±0.6 for patients with CKD; P<0.001), p-cresol sulfate (8.6±2.6 for controls versus 4.1±1.5 for patients with CKD; P<0.001), and indoxyl sulfate (23.0±7.3 versus 7.5±2.8; P<0.001) but not for hippurate (10.2±3.8 versus 8.4±2.6; P=0.13). CONCLUSIONS: Secretory clearances for many solutes are reduced more than the GFR in advanced CKD. Impaired secretion of these solutes might contribute to uremic symptoms as patients approach dialysis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Mair RD, Lee S, Plummer NS, et al. Impaired Tubular Secretion of Organic Solutes in Advanced Chronic Kidney Disease. J Am Soc Nephrol. 2021. PMID: 34408065. doi:10.1681/ASN.2021030336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。